Search Browse Earnings

Pluri Inc. — SlamSEC

Pluri Inc.

Nasdaq:PLUR

Biological Products, (No Diagnostic Substances)·HAIFA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$326,000

+13.6% YoY

FY 2025

Adj. EBITDA

-$21.9M

-6719.3% margin

FY 2025

Net Income

-$20.9M

-6407.4% margin

FY 2025

EPS (Diluted)

-$3.99

FY 2025

Stock Price

$3.37

+2.7%

2026-03-09

52W Range

$2.82 – $7.13

P/E Ratio

-0.8x

Market Cap

$33.9M

Cash

$6.8M

FY 2025

Total Debt

$1.3M

FY 2020

Net Cash

$5.5M

FY 2020

Enterprise Value

$28.3M

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-1.3x

Employees

—

CEO

Yanay Yaky

CFO

Zalts Liat